The change is expected to save at least 90 days in the drug development life cycle — a major boost for research timelines and ...

The Union Health Ministry has eased pharmaceutical regulations, allowing companies to start drug development and low-risk ...

To reduce regulatory burden and promote ease of doing business, the Centre has amended the New Drugs and Clinical Trials ...

The Union Ministry of Health and Family Welfare has taken a series of measures including simplification of regulatory processes and reduction of drug approval timelines to facilitate and speed up the ...

With an aim to streamline pharmaceutical development, the Union Health Ministry has notified amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019. Under the new regulations, ...

Health Ministry amends New Drugs and Clinical Trials Rules to streamline regulations, reduce approval times, and boost ...

The Union Ministry of Health and Family Welfare on Wednesday notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, aimed at reducing drug development timelines and ...

The Centre has notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, in line with the directions of Prime Minister Narendra Modi to reduce regulatory burden and promote ease ...

New regulations streamline drug development by eliminating test licenses for many drugs, replacing them with online ...

India, Jan. 29 -- Pharma companies will no longer be required to seek a test licence and may proceed with pharmaceutical ...

Q4 2025 Earnings Call January 28, 2026 8:00 AM ESTCompany ParticipantsJohn Bedford - Vice President of Investor ...